| Synapse-Associated Protein 97 | |
|---|---|
| Protein Name | Synapse-Associated Protein 97 |
| Gene Symbol | DLG1 |
| UniProt ID | Q12959 |
| PDB Structures | 1W0O, 2EWF |
| Molecular Weight | 102 kDa |
| Subcellular Localization | Postsynaptic density, Cytoplasm, Nucleus |
| Protein Family | MAGUK (Membrane-Associated Guanylate Kinase) Family |
Synapse-Associated Protein 97 (SAP97), encoded by the DLG1 gene, is a 102 kDa postsynaptic scaffolding protein and a founding member of the Membrane-Associated Guanylate Kinase (MAGUK) family[1]. SAP97 organizes synaptic receptors, ion channels, and signaling molecules at the postsynaptic density (PSD), making it essential for synaptic transmission, plasticity, and ultimately learning and memory. Dysregulation of SAP97 has been implicated in Alzheimer's Disease, where it regulates amyloid-beta toxicity and apoptosis pathways, and in several neurodevelopmental disorders[2].
The DLG1 gene is located on chromosome 3q29 and encodes a 926-amino acid protein. DLG1 is ubiquitously expressed with particularly high levels in neurons, especially in the hippocampus and cortex. Alternative splicing produces multiple SAP97 isoforms with distinct subcellular distributions — some isoforms are targeted to synapses while others are retained in the cytoplasm or shuttle to the nucleus.
SAP97 is a MAGUK family protein with characteristic multi-domain architecture[1:1]:
| Isoform | Distribution | Key Features |
|---|---|---|
| SAP97α | Postsynaptic density | Synaptic targeting via palmitoylation |
| SAP97β | Cytoplasm | AKAP interaction, signaling roles |
| SAP97γ | Neuronal nucleus | Transcriptional regulation |
Palmitoylation of SAP97α at the N-terminus targets it to the postsynaptic density, where it accumulates during synaptic maturation.
SAP97 is a master scaffold at excitatory synapses[3]:
AMPA Receptor Anchoring: SAP97 directly binds the GluA1 and GluA2/3 subunits of AMPA receptors via its PDZ domains. SAP97 helps recruit AMPA receptors to the postsynaptic membrane during synaptic development and plasticity.
NMDA Receptor Interaction: Through its PDZ domains, SAP97 interacts with NMDA receptor subunits (NR1, NR2A, NR2B)[4]. This interaction is modulated by kinase phosphorylation — CaMKII phosphorylation of SAP97 strengthens NMDA receptor anchoring.
Ion Channel Scaffolding: SAP97 scaffolds Kv1 channels, Kir channels, and other ion channels at the PSD, regulating neuronal excitability.
Adhesion Molecules: SAP97 binds neurexin-neuroligin complexes and other synaptic adhesion molecules, coordinating pre- and postsynaptic organization.
Beyond receptor anchoring, SAP97 coordinates signaling cascades:
The SAP97β/γ isoforms lack synaptic targeting signals and localize to the cytoplasm and nucleus. Nuclear SAP97 may participate in transcriptional regulation, though this function is less well characterized.
SAP97 is implicated in AD through multiple mechanisms[2:1]:
AMPA Receptor Dysregulation: In AD, APP/amyloid pathology disrupts SAP97-mediated AMPA receptor trafficking. Amyloid-beta reduces SAP97 expression and alters its phosphorylation, impairing synaptic AMPA receptor function and contributing to spine loss.
NMDA Receptor Signaling: SAP97 coordinates NMDA receptor signaling at the PSD. In AD, NMDA receptor overactivation (excitotoxicity) is a major driver of neuronal death. SAP97 scaffolds both receptors and their downstream signaling effectors.
Synaptic Plasticity Impairment: SAP97 is required for long-term potentiation (LTP) and long-term depression (LTD). Disruption of SAP97 function by amyloid-beta likely contributes to the memory deficits that define AD.
Apoptotic Pathways: SAP97 interacts with pro-apoptotic proteins and can modulate cell death pathways in stressed neurons. Amyloid-beta toxicity involves SAP97-dependent signaling to caspase activation.
SAP97/DLG1 has been linked to:
DLG1 is also implicated in cancer biology as a tumor suppressor. Loss of DLG1 promotes epithelial-mesenchymal transition and metastasis in several carcinomas.
SAP97 presents challenges as a therapeutic target due to its broad synaptic roles:
| Protein | Interaction Type | Functional Significance |
|---|---|---|
| GluA1/Gria1 AMPA receptor | PDZ binding | Synaptic AMPA receptor anchoring |
| GluA2/Gria2 AMPA receptor | PDZ binding | Synaptic AMPA receptor anchoring |
| [GRIN1/NR1](/genes grin1) NMDA receptor | PDZ binding | NMDA receptor scaffolding |
| GRIN2A/NR2A NMDA receptor | PDZ binding | NMDA receptor signaling |
| CaMK2A/CaMKII | Kinase phosphorylation | Plasticity regulation |
| AKAP79/150 | L27 domain binding | PKA/calcineurin recruitment |
| PSD-95/DLG4 | MAGUK family | Synaptic scaffold network |
| CASK | L27 domain binding | Presynaptic partner |
| beta-catenin | GK domain | Cytoskeletal linkage |
SAP97 is essential for activity-dependent synaptic modifications[3:1]:
Long-Term Potentiation (LTP): During LTP induction, CaMKII phosphorylates SAP97, strengthening AMPA receptor insertion at the PSD. SAP97-mediated AMPA receptor delivery is a core mechanism of LTP expression.
Long-Term Depression (LTD): SAP97 is also involved in LTD, where it facilitates AMPA receptor internalization downstream of NMDA receptor activation and endocannabinoid signaling.
Homeostatic Scaling: SAP97 participates in homeostatic synaptic scaling, where neurons adjust synaptic strength globally in response to activity perturbations.
Kim E, Sheng M. PDZ domain proteins of synapses. Nature Reviews Neuroscience. 2004. ↩︎ ↩︎
Chen YJ, et al. SAP97 in Alzheimer's disease: synaptic dysfunction and therapeutic targeting. Journal of Alzheimer's Disease. 2019. ↩︎ ↩︎
Elias GM, Nicoll RA. Synaptic trafficking of AMPA receptors. Trends in Neurosciences. 2007. ↩︎ ↩︎
Gardoni F, et al. SAP97, a synaptic scaffold protein, in NMDA receptor regulation. Neuropharmacology. 2012. ↩︎